|
ARMCX1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.30131494258512E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.04660765901599E-12 |
| Normal-vs-Stage2 |
1.901280E-03 |
| Normal-vs-Stage3 |
1.447360E-01 |
| Normal-vs-Stage4 |
7.297600E-03 |
| Stage1-vs-Stage2 |
7.419400E-01 |
| Stage1-vs-Stage3 |
1.888420E-01 |
| Stage1-vs-Stage4 |
3.438200E-01 |
| Stage2-vs-Stage3 |
3.605600E-01 |
| Stage2-vs-Stage4 |
3.562600E-01 |
| Stage3-vs-Stage4 |
1.916800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.96365146365451E-12 |
| Normal-vs-AfricanAmerican |
6.235700E-03 |
| Normal-vs-Asian |
2.724400E-01 |
| Caucasian-vs-AfricanAmerican |
4.668100E-02 |
| Caucasian-vs-Asian |
8.722600E-01 |
| AfricanAmerican-vs-Asian |
6.544600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.74935671188359E-14 |
| Normal-vs-Female |
3.879200E-03 |
| Male-vs-Female |
2.719500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.027570E-02 |
| Normal-vs-Extreme_Weight |
1.65933933260476E-12 |
| Normal-vs-Obese |
3.51049999958164E-07 |
| Normal-vs-Extreme_Obese |
1.894250E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.500630E-01 |
| Normal_Weight-vs-Obese |
5.546000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.049800E-01 |
| Extreme_Weight-vs-Obese |
1.804050E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.657600E-01 |
| Obese-vs-Extreme_Obese |
9.231400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.98039999999811E-05 |
| Normal-vs-Age(41-60Yrs) |
1.22400000002187E-06 |
| Normal-vs-Age(61-80Yrs) |
1.58562052376965E-12 |
| Normal-vs-Age(81-100Yrs) |
5.375400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.253900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.763160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.507580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.381700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.230000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.883000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.25075513782258E-12 |
| Normal-VS-Type2 PRCC |
1.363100E-03 |
| Normal-VS-KIRP CIMP |
<1E-12 |
| Normal-VS-Unclassified PRCC |
5.461800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.387200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
<1E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
7.085900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.87789783723247E-11 |
| Type2 PRCC-VS-Unclassified PRCC |
6.666600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.45079545336102E-11 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.47440000395494E-08 |
| Normal-vs-N1 |
1.082970E-01 |
| Normal-vs-N2 |
1.72754999999691E-05 |
| N0-vs-N1 |
4.927400E-01 |
| N0-vs-N2 |
3.901800E-01 |
| N1-vs-N2 |
4.652800E-01 |
|
|
